Gene: CCPG1
Official Full Name: cell cycle progression 1provided by HGNC
Gene Summary: Involved in positive regulation of cell cycle and positive regulation of cell population proliferation. Predicted to be active in membrane. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO33430 | CCPG1 Knockout cell line (HeLa) | Human | CCPG1 | 1:3~1:6 | Negative | Online Inquiry |
KO33431 | CCPG1 Knockout cell line (HCT 116) | Human | CCPG1 | 1:2~1:4 | Negative | Online Inquiry |
KO33432 | CCPG1 Knockout cell line (HEK293) | Human | CCPG1 | 1:3~1:6 | Negative | Online Inquiry |
KO33433 | CCPG1 Knockout cell line (A549) | Human | CCPG1 | 1:3~1:4 | Negative | Online Inquiry |
CCPG1 Gene Knockout Cell Lines represent a sophisticated tool designed for the exploration of cellular mechanisms and the functional relevance of the CCPG1 gene, which has been implicated in various biological processes, including cell proliferation and apoptosis. These engineered cell lines are created through advanced CRISPR/Cas9 gene-editing technology, allowing for precise disruption of the CCPG1 gene, thereby providing a platform for studying the resulting phenotypic changes and underlying pathways.
The primary function of CCPG1 Gene Knockout Cell Lines is to enable researchers to investigate the role of CCPG1 in various cellular activities and its contribution to disease pathology. By observing the behavior and response of these knockout cells under different experimental conditions, such as drug treatment or stress-induced environments, scientists can gain valuable insights into the cellular mechanisms regulated by CCPG1. This understanding can be crucial for advancing therapeutic strategies in conditions where CCPG1 is a key player.
In research and clinical settings, the importance of studying CCPG1 cannot be overstated. Alterations in CCPG1 expression have been linked to several malignancies, making these knockout cell lines invaluable for cancer research. They offer a controlled system to analyze how the loss of CCPG1 affects tumorigenesis, cellular signaling pathways, and drug response, thus facilitating the identification of potential therapeutic targets.
What sets CCPG1 Gene Knockout Cell Lines apart from traditional methods is their high specificity and reproducibility, resulting from the CRISPR/Cas9 approach. Unlike older genetic manipulation techniques, these cell lines demonstrate precise gene editing, minimizing off-target effects and ensuring that researchers obtain reliable data. Additionally, our line of CCPG1 knockout cells is readily available and can be easily integrated into existing experimental frameworks, drastically reducing the time required for setup.
For researchers and clinicians, the value of CCPG1 Gene Knockout Cell Lines lies not only in their ability to illuminate the functions of the CCPG1 gene but also in their role as a step towards the development of innovative therapies. With our company’s expertise in providing high-quality biological products and cutting-edge technologies, we continue to support scientific advancement across various fields, empowering researchers to push the boundaries of knowledge in cellular biology.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.